drugset / Trial / NCT06979388

A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.

NCT06979388

Phase 1 Completed 14 enrolled AstraZeneca Parexel · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The main purpose of this study is to assess the effect of food on balcinrenone/ dapagliflozin pharmacokinetics in fed and fasted state and pharmacokinetics of balcinrenone when dosed with a P-gp inhibitor in healthy participants.

Timeline

Start
2025-05-20
Primary completion
2025-07-12
Completion
2025-07-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule
Subject balcinrenone Small molecule
Background Quinidine Small molecule Oral

Indications

No indication recorded.